SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-24-100011
Filing Date
2024-09-16
Accepted
2024-09-16 08:12:17
Documents
23
Effectiveness Date
2024-09-16

Document Format Files

Seq Description Document Type Size
1 F-3ASR tm2423681-2_f3asr.htm F-3ASR 316158
2 EXHIBIT 1.1 tm2423681d3_ex1-1.htm EX-1.1 166572
3 EXHIBIT 4.2 tm2423681d3_ex4-2.htm EX-4.2 74366
4 EXHIBIT 5.1 tm2423681d3_ex5-1.htm EX-5.1 10873
5 EXHIBIT 5.2 tm2423681d3_ex5-2.htm EX-5.2 44124
6 EXHIBIT 23.3 tm2423681d3_ex23-3.htm EX-23.3 1788
7 EXHIBIT 23.4 tm2423681d3_ex23-4.htm EX-23.4 2816
8 EXHIBIT 25.1 tm2423681d3_ex25-1.htm EX-25.1 57211
9 EX-FILING FEES tm2423681d2_ex-filingfees.htm   iXBRL EX-FILING FEES 20253
10 GRAPHIC lg_novartis-4c.jpg GRAPHIC 26070
11 GRAPHIC tm2423681d3_ex23-4img001.jpg GRAPHIC 2799
12 GRAPHIC tm2423681d3ex5-2img001.jpg GRAPHIC 8279
  Complete submission text file 0001104659-24-100011.txt   873208

Data Files

Seq Description Document Type Size
26 EXTRACTED XBRL INSTANCE DOCUMENT tm2423681d2_ex-filingfees_htm.xml XML 5585
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-3ASR | Act: 33 | File No.: 333-282133 | Film No.: 241299388
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 608 FIFTH AVENUE NEW YORK NY 10020
Business Address 608 FIFTH AVENUE NEW YORK NY 10020 (212)307 1122
Novartis Capital CORP (Filer) CIK: 0001443411 (see all company filings)

IRS No.: 263086456 | State of Incorp.: DE | Fiscal Year End: 1231
Type: F-3ASR | Act: 33 | File No.: 333-282133-01 | Film No.: 241299389
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)